| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.42B | 14.19B | 14.27B | 14.00B | 15.48B | 35.71B |
| Gross Profit | 6.17B | 6.17B | 6.70B | 6.28B | 6.95B | 8.16B |
| EBITDA | -552.76M | -57.72M | 1.89B | 999.77M | 519.36M | 2.11B |
| Net Income | -404.50M | -530.40M | 1.01B | 254.88M | 310.44M | 1.43B |
Balance Sheet | ||||||
| Total Assets | 28.61B | 29.53B | 27.08B | 25.41B | 25.09B | 27.07B |
| Cash, Cash Equivalents and Short-Term Investments | 8.93B | 10.10B | 12.86B | 14.31B | 13.77B | 17.97B |
| Total Debt | 16.49B | 17.11B | 11.66B | 9.47B | 10.26B | 11.55B |
| Total Liabilities | 19.44B | 20.20B | 16.28B | 15.44B | 15.44B | 17.33B |
| Stockholders Equity | 9.05B | 9.20B | 10.66B | 9.80B | 9.39B | 9.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.20B | -424.17M | 1.56B | 38.14M | 2.31B |
| Operating Cash Flow | 0.00 | -1.14B | -385.00M | 1.59B | 683.15M | 2.43B |
| Investing Cash Flow | 0.00 | -6.59B | -1.64B | -708.65M | -1.28B | 72.71M |
| Financing Cash Flow | 0.00 | 4.63B | 572.01M | -345.60M | -692.96M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥34.66B | 18.53 | ― | ― | 27.97% | -5.25% | |
70 Outperform | ¥42.19B | 18.86 | ― | ― | ― | ― | |
68 Neutral | ¥22.29B | 42.84 | ― | ― | 14.28% | -30.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | ¥6.55B | -15.11 | ― | ― | -12.37% | 12.44% | |
49 Neutral | ¥27.41B | 29.06 | ― | ― | 20.84% | 10.41% | |
48 Neutral | ¥13.03B | 57.10 | ― | 3.48% | -11.85% | ― |